Corifollitropin Alfa Followed by Hp-HMG Versus Recombinant FSH in Young Poor Ovarian Responders. A Multicentre Randomized Controlled Clinical Trial
Phase of Trial: Phase III
Latest Information Update: 27 Jun 2016
At a glance
- Drugs Corifollitropin alfa (Primary) ; Ganirelix (Primary) ; Menotropin (Primary) ; Urofollitropin
- Indications Infertility
- Focus Therapeutic Use
- Acronyms COMPORT
- 31 Aug 2018 Biomarkers information updated
- 21 Jun 2016 Status changed from recruiting to completed.
- 16 Jun 2016 The trial was completed in Belgium.